Obg3 globular head and uses thereof for decreasing body mass
CA 2383136 C · Owner: Bihain, Bernard · Inventors: Bihain, Bernard; Yen-Potin, Frances; Erickson, Mary Ruth
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound globular , OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes and hypertension.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 10, 2001 and granted September 18, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 10, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 10, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.